MicroRNA-155 Deficiency Promotes Nephrin Acetylation and Attenuates Renal Damage in Hyperglycemia-Induced Nephropathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-155 Deficiency Promotes Nephrin Acetylation and Attenuates Renal Damage in Hyperglycemia-Induced Nephropathy
Authors
Keywords
MiR-155, nephropathy, nephrin acetylation, IL-17A, SOCS1
Journal
INFLAMMATION
Volume 38, Issue 2, Pages 546-554
Publisher
Springer Nature
Online
2014-06-26
DOI
10.1007/s10753-014-9961-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-29a Promotion of Nephrin Acetylation Ameliorates Hyperglycemia-Induced Podocyte Dysfunction
- (2014) C.-L. Lin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rheumatoid Arthritis-Associated MicroRNA-155 Targets SOCS1 and Upregulates TNF-α and IL-1β in PBMCs
- (2013) Xiaochuan Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reversibility of Structural and Functional Damage in a Model of Advanced Diabetic Nephropathy
- (2013) W. Pichaiwong et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Role of Th17/IL-17 in the Pathogenesis of Primary Nephrotic Syndrome in Children
- (2013) Li Wang et al. KIDNEY & BLOOD PRESSURE RESEARCH
- SIRPαinteracts with nephrin at the podocyte slit diaphragm
- (2012) Yuko Kajiho et al. FEBS Journal
- Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease
- (2012) Britta George et al. JOURNAL OF CLINICAL INVESTIGATION
- eNOS Deficiency Predisposes Podocytes to Injury in Diabetes
- (2012) D. A. Yuen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1
- (2012) Rui Yao et al. PLoS One
- Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome
- (2011) Li-li Liu et al. CLINICAL IMMUNOLOGY
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
- (2011) Ken Inoki et al. JOURNAL OF CLINICAL INVESTIGATION
- Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis
- (2011) G. Murugaiyan et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
- (2010) S. Jiang et al. CANCER RESEARCH
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
- (2010) Ryan M. O'Connell et al. IMMUNITY
- Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1
- (2010) P. Wang et al. JOURNAL OF IMMUNOLOGY
- The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis
- (2010) Lindsey D. Jager et al. JOURNAL OF NEUROIMMUNOLOGY
- LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages
- (2009) Tina Ruggiero et al. FASEB JOURNAL
- Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 Protein
- (2009) Li-Fan Lu et al. IMMUNITY
- Nephrin Deficiency Activates NF- B and Promotes Glomerular Injury
- (2009) S. Hussain et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dickkopf-1 Promotes Hyperglycemia-Induced Accumulation of Mesangial Matrix and Renal Dysfunction
- (2009) C.-L. Lin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Wnt/ -Catenin Signaling Promotes Podocyte Dysfunction and Albuminuria
- (2009) C. Dai et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome
- (2009) Xiao Shan Shao et al. PEDIATRIC NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started